CT Vacinas

CT Vacinas is a prominent Brazilian biotechnology research and development center dedicated to the advancement of vaccines and diagnostic technologies. Affiliated with the Federal University of Minas Gerais (UFMG) and Fiocruz, the center is located within the Belo Horizonte Technology Park (BH-TEC). It gained significant recognition for the development of SpiN-TEC, a second-generation COVID-19 vaccine designed to induce a robust cellular immune response by targeting both the Spike and Nucleocapsid proteins. The center's expertise spans recombinant protein production, molecular biology, and immunology, with a specific focus on neglected tropical diseases like leishmaniasis and Chagas disease. CT Vacinas serves as a critical link in the Brazilian health innovation chain, transitioning basic scientific discoveries into clinical-stage products.